Related Experiment Video
Updated: Jan 31, 2026

Anteromesial Temporal Lobectomy for Medically Intractable Temporal Lobe Epilepsy: An Operative Study
Published on: August 15, 2025
Human and rodent temporal lobe epilepsy is characterized by changes in O-GlcNAc homeostasis that can be reversed to
Richard G Sánchez1, R Ryley Parrish2, Megan Rich1
1Department of Neurobiology, University of Alabama, Birmingham, AL, United States.
Abstract:
Temporal Lobe Epilepsy (TLE) is frequently associated with changes in protein composition and post-translational modifications (PTM) that exacerbate the disorder. O-linked-β-N-acetyl glucosamine (O-GlcNAc) is a PTM occurring at serine/threonine residues that is derived from and closely associated with metabolic substrates. The enzymes O-GlcNActransferase (OGT) and O-GlcNAcase (OGA) mediate the addition and removal, respectively, of the O-GlcNAc modification. The goal of this study was to characterize OGT/OGA and protein O-GlcNAcylation in the epileptic hippocampus and to determine and whether direct manipulation of these proteins and PTM's alter epileptiform activity. We observed reduced global and protein specific O-GlcNAcylation and OGT expression in the kainate rat model of TLE and in human TLE hippocampal tissue. Inhibiting OGA with Thiamet-G elevated protein O-GlcNAcylation, and decreased both seizure duration and epileptic spike events, suggesting that OGA may be a therapeutic target for seizure control. These findings suggest that loss of O-GlcNAc homeostasis in the kainate model and in human TLE can be reversed via targeting of O-GlcNAc related pathways.
Insights
Temporal Lobe Epilepsy (TLE) involves altered protein modifications. Inhibiting O-GlcNAcase (OGA) restored O-GlcNAc levels and reduced seizure activity, suggesting OGA as a therapeutic target for TLE.
Area of Science:
- Neuroscience
- Biochemistry
- Epilepsy Research
Background:
- Temporal Lobe Epilepsy (TLE) is linked to protein changes and post-translational modifications (PTMs).
- O-linked-β-N-acetyl glucosamine (O-GlcNAc) is a PTM tied to metabolic substrates, regulated by O-GlcNAc transferase (OGT) and O-GlcNAc glycosidase (OGA).
Purpose of the Study:
- To investigate OGT/OGA and O-GlcNAc levels in the epileptic hippocampus.
- To determine if manipulating OGT/OGA and O-GlcNAc affects epileptiform activity.
Main Methods:
- Utilized the kainate rat model of TLE and human TLE hippocampal tissue.
- Assessed global and protein-specific O-GlcNAcylation and OGT expression.
- Administered OGA inhibitor Thiamet-G to evaluate its effects on O-GlcNAcylation and seizure activity.
Main Results:
- Reduced O-GlcNAc levels and OGT expression were observed in both the kainate model and human TLE hippocampus.
- Inhibition of OGA with Thiamet-G increased O-GlcNAc levels.
- Thiamet-G treatment decreased seizure duration and epileptic spike frequency.
Conclusions:
- Loss of O-GlcNAc homeostasis is implicated in TLE.
- Targeting OGA can restore O-GlcNAc homeostasis and potentially control seizures in TLE.
- OGA inhibition presents a potential therapeutic strategy for TLE seizure management.
More Related Videos
Related Concept Videos
What is Homeostasis?
pH Homeostasis
Respiratory...
Lobes of the Cerebrum
Frontal lobe
The frontal lobes, located behind the forehead, are the command center of our brain, controlling personality, intelligence, and voluntary muscle movements....
Skeleton and Calcium Homeostasis
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Glucose Homeostasis: Regulation of Blood Glucose
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...

